MedPath

The effect of Adductor-Channel Blockade with high pain responders after reconstruction of the anterior cruciate ligament

Conditions
Patients who will undergo reconstruktion of ligament cruciate ligament.
MedDRA version: 14.1Level: LLTClassification code 10036236Term: Postoperative pain reliefSystem Organ Class: 100000004865
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2013-000663-83-DK
Lead Sponsor
Rigshospitalet
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Age> 18 years and <80 years
• Patients in the recovery ward (before discharge to home) indicates a postoperative VAS score = 40 at 45 degrees inward inflexion of the knee after reconstruction of the anterior cruciate ligament (ACL) with a hamstring graft with general anesthesia and without administration of opioid in the last 30 minutes before inclusion.
• Patients who have given written informed consent to participate in the study after having understood the contents of the protocol and limitations in full.
• ASA I-III.
• BMI> 18 and <40
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

Patients who are operating in blood emptiness (used a cuff)
• Patients who can not cooperate with the investigation.
• Patients who do not understand or speak Danish.
• Allergy to those used in the study drugs.
• Pregnancy, studied with HCG urinstiks on the day of surgery when possible pregnancy.
• Alcohol and / or drug abuse - the investigator's opinion.
• Daily consumption of opioid
• Infection at the injection area

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Objective: Not applicable;Primary end point(s): •Forskel i smertescore ved 45 graders aktiv flektion af knæled 45 minutter (t45) efter anlæggelse af AKB med 30 mL ropivacain 7.5 mg/mL versus placebo;Timepoint(s) of evaluation of this end point: painscore at the time 45 and 90 minutes after studydrug has been given<br>;Main Objective: The purpose of this study is to investigate the analgesic effect of BAC in patients with moderate to severe pain (VAS = 40 mm) after reconstruction of the anterior cruciate ligament (hamstring graft). The hypothesis is that the BAC will reduce post-operative pain, maintain muscle strength, and to reduce the post-operative use of opioid compared to placebo.<br>The purpose of the study is therefore to clarify whether BAC can and should be used in the subgroup of patients who have moderate to severe pain after cruciate ligament
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): The difference in pain scores at rest 45 minutes (t45) after the construction of BAC with 30 mL of ropivacaine 7.5 mg / mL versus placebo.<br>• The difference in pain scores at 45 degrees inward inflexion of knee 90 minutes (t90) after the construction of BAC between the two treatment groups<br>• The difference in pain scores at rest 90 minutes (t90) after the construction of BAC between the two treatment groups<br>• Maximum pain (VAS) for 5 meter walk and with full load on the operated leg at times t45 and t90<br>• Patient assessment of change in muscle strength after BAC assessed within the 5 meter walk to the times t45 and t90;Timepoint(s) of evaluation of this end point: painscore at the time 45 and 90 minutes after studydrug has been given
© Copyright 2025. All Rights Reserved by MedPath